A comment left by Jim on the post below brings up the question about an experimental drug discussed in the Still Alice book I mentioned. To answer your question, Jim, I'm not positive about which drug in particular Lisa was talking about in her book, but about the time the book was being published, a drug was very close to being brought to market called Alzhamed. However, the clinical trials did not come out as good as the pharmaceutical company was hoping for and the drug was not marketed afterall. The only drugs I know of at the moment are Aricept, Exelon, Razadyne and Namenda. Namenda is usually taken in conjunction with one of the other three drugs. I belieive this is correct, but if someone else is reading this I'm sure they will correct me if I am wrong. Many of us had our hopes up for the Alzhamed drug -- but there are several other drugs still in the pipeline in clinical trials. Perhaps if Lisa looks at the blog she may also be able to address this issue. And, I do agree with you that Still Alice is sad.....but so is this disease. Thanks for your comments.
Another event that I wanted to mention is another event happening here in Georgia. It is being hosted by the Georgia Chapter of the Alzheimer's Association. The speakers are great --I've heard many of them, so if you can spare a day on January 23rd, you might want to check it out. The link is http://www.alz.org/georgia/in_my_community_education.asp.
Wednesday, January 02, 2008
Subscribe to:
Post Comments (Atom)
2 comments:
Can you explain why you have trouble talking on the phone? How does it affect you? Do you get distracted? Just curious -- my mom doesn't call very many people any longer. D
Hi, good blog site. Re drug trials for alzheimers a comprehensive list is being compiled and access to this will be possible through www.alzheimerssupport.net in a couple of months.
Post a Comment